Diseases of the nervous system
Conditions
Interventions
Safety Assessment Group:Participants are required to close their eyes while the AI monitoring system starts working to record pupil images. During this period, avoid direct sunlight and external inter
Prospective single-arm self-control Group:The infrared LEDs placed on the temples emit a continuous 0. 1 second of pulsed light
Wait 0.2 sec and use a 1 sec white LED pulse to irradiate the subject's eyes directly from the front
Sponsors
Drum Tower Hospital, The Affiliated to Nanjing University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Part I: No history of eye disease, no recent eye surgery or drug use; 2.Part II: Have certain clinical experience in the medical field (doctors with the title of attending physician or above, and nurses with at least three years of working experience), and have participated in the prototype use of the system or related research projects; be able to express their opinions fluently; sign informed consent form before interview, agree to voluntarily participate and authorize the research team to use the interview content as research data; 3.Part III: Critically ill patients diagnosed with neurological related diseases, such as central nervous system infectious diseases, etc., and required to have a diagnosis certificate from a medical professional; the patient's disease state remained stable in the near future, without acute attacks or significant deterioration trends; participants needed to be able to maintain stable eye closure for at least 5 seconds to ensure effective detection of pupil change devices; patients had no cognitive impairment or communication difficulties; informed consent, voluntary signing of informed consent form;
Exclusion criteria
Exclusion criteria: 1. Patients with severe eye diseases or obvious abnormal pupils in the closed eye, such as poor pupil dilation, fixed and unchanged, etc.; 2. Complications such as discomfort with closed eyes or light sensitivity; 3. Suffering from other serious neurological diseases that may affect pupillary function or cognition, such as Alzheimer's disease, advanced Parkinson's disease, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assess for reactions such as eye discomfort, irritation, or light sensitivity when using the pupil monitoring system;Monitoring accuracy, clinical suitability and safety of the system; | — |
Countries
China
Contacts
Public ContactChen Lu
Drum Tower Hospital, The Affiliated to Nanjing University School of Medicine
Outcome results
None listed